Passaniti A - Search Results

1

Identification of Cross Talk between FoxM1 and RASSF1A as a Therapeutic Target of Colon Cancer.

Blanchard TG, Czinn SJ, Banerjee V, Sharda N, Bafford AC, Mubariz F, Morozov D, Passaniti A, Ahmed H, Banerjee A. Blanchard TG, et al. Among authors: passaniti a. Cancers (Basel). 2019 Feb 8;11(2):199. doi: 10.3390/cancers11020199. Cancers (Basel). 2019. PMID: 30744076 Free PMC article.

2

Metformin and Androgen Receptor-Axis-Targeted (ARAT) Agents Induce Two PARP-1-Dependent Cell Death Pathways in Androgen-Sensitive Human Prostate Cancer Cells.

Xie Y, Wang L, Khan MA, Hamburger AW, Guang W, Passaniti A, Munir K, Ross DD, Dean M, Hussain A. Xie Y, et al. Among authors: passaniti a. Cancers (Basel). 2021 Feb 5;13(4):633. doi: 10.3390/cancers13040633. Cancers (Basel). 2021. PMID: 33562646 Free PMC article.

3

Roles of RUNX in Hippo Pathway Signaling.

Passaniti A, Brusgard JL, Qiao Y, Sudol M, Finch-Edmondson M. Passaniti A, et al. Adv Exp Med Biol. 2017;962:435-448. doi: 10.1007/978-981-10-3233-2_26. Adv Exp Med Biol. 2017. PMID: 28299672 Free PMC article. Review.

4

Characterization of CADD522, a small molecule that inhibits RUNX2-DNA binding and exhibits antitumor activity.

Kim MS, Gernapudi R, Choi EY, Lapidus RG, Passaniti A. Kim MS, et al. Among authors: passaniti a. Oncotarget. 2017 Aug 10;8(41):70916-70940. doi: 10.18632/oncotarget.20200. eCollection 2017 Sep 19. Oncotarget. 2017. PMID: 29050333 Free PMC article.

5

Targeting mitochondrial metabolism for metastatic cancer therapy.

Passaniti A, Kim MS, Polster BM, Shapiro P. Passaniti A, et al. Mol Carcinog. 2022 Sep;61(9):827-838. doi: 10.1002/mc.23436. Epub 2022 Jun 20. Mol Carcinog. 2022. PMID: 35723497 Free PMC article. Review.

6

ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer.

Zhang Y, Ali TZ, Zhou H, D'Souza DR, Lu Y, Jaffe J, Liu Z, Passaniti A, Hamburger AW. Zhang Y, et al. Among authors: passaniti a. Cancer Res. 2010 Jan 1;70(1):240-8. doi: 10.1158/0008-5472.CAN-09-2904. Cancer Res. 2010. PMID: 20048076 Free PMC article.

7

A positive feedback loop involving EGFR/Akt/mTORC1 and IKK/NF-kB regulates head and neck squamous cell carcinoma proliferation.

Li Z, Yang Z, Passaniti A, Lapidus RG, Liu X, Cullen KJ, Dan HC. Li Z, et al. Among authors: passaniti a. Oncotarget. 2016 May 31;7(22):31892-906. doi: 10.18632/oncotarget.7441. Oncotarget. 2016. PMID: 26895469 Free PMC article.

8

The RUNX2 Transcription Factor Negatively Regulates SIRT6 Expression to Alter Glucose Metabolism in Breast Cancer Cells.

Choe M, Brusgard JL, Chumsri S, Bhandary L, Zhao XF, Lu S, Goloubeva OG, Polster BM, Fiskum GM, Girnun GD, Kim MS, Passaniti A. Choe M, et al. Among authors: passaniti a. J Cell Biochem. 2015 Oct;116(10):2210-26. doi: 10.1002/jcb.25171. J Cell Biochem. 2015. PMID: 25808624 Free PMC article.

9

Targeting breast cancer metabolism with a novel inhibitor of mitochondrial ATP synthesis.

Kim MS, Gernapudi R, Cedeño YC, Polster BM, Martinez R, Shapiro P, Kesari S, Nurmemmedov E, Passaniti A. Kim MS, et al. Among authors: passaniti a. Oncotarget. 2020 Oct 27;11(43):3863-3885. doi: 10.18632/oncotarget.27743. eCollection 2020 Oct 27. Oncotarget. 2020. PMID: 33196708 Free PMC article.

10

RUNX2 and TAZ-dependent signaling pathways regulate soluble E-Cadherin levels and tumorsphere formation in breast cancer cells.

Brusgard JL, Choe M, Chumsri S, Renoud K, MacKerell AD Jr, Sudol M, Passaniti A. Brusgard JL, et al. Among authors: passaniti a. Oncotarget. 2015 Sep 29;6(29):28132-50. doi: 10.18632/oncotarget.4654. Oncotarget. 2015. PMID: 26320173 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters